Evidence map›Paper›PMID 27799768›Full record

ArticleInternational journal of nanomedicine

Core-shell magnetic nanoparticles display synergistic antibacterial effects against

Katarzyna Niemirowicz, Ewelina Piktel, Agnieszka Z Wilczewska, Karolina H Markiewicz, Bonita Durnaś, Marzena Wątek, Irena Puszkarz, Marta Wróblewska, Wiesława Niklińska, Paul B Savage and 1 more

Abstract read
In one paragraph

Article in International journal of nanomedicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Overexpression of theFrontiers in microbiology · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Katarzyna NiemirowiczDepartment of Microbiological and Nanobiomedical Engineering, Medical University of Białystok.
Ewelina PiktelDepartment of Microbiological and Nanobiomedical Engineering, Medical University of Białystok.
Agnieszka Z WilczewskaInstitute of Chemistry, University of Białystok, Białystok.
Karolina H MarkiewiczInstitute of Chemistry, University of Białystok, Białystok.
Bonita DurnaśDepartment of Physiology, Pathophysiology and Immunology of Infections, The Faculty of Health Sciences of the Jan Kochanowski University in Kielce.
Marzena WątekHoly Cross Oncology Center of Kielce, Kielce.
Irena PuszkarzDepartment of Physiology, Pathophysiology and Immunology of Infections, The Faculty of Health Sciences of the Jan Kochanowski University in Kielce.
Marta WróblewskaDepartment of Dental Microbiology, Medical University of Warsaw; Department of Microbiology, Central Clinical Hospital in Warsaw, Warsaw.
Wiesława NiklińskaDepartment of Histology and Embryology, Medical University of Bialystok, Białystok, Poland.
Paul B SavageDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, UT, USA.
Robert BuckiDepartment of Microbiological and Nanobiomedical Engineering, Medical University of Białystok; Department of Physiology, Pathophysiology and Immunology of Infections, The Faculty of Health Sciences of the Jan Kochanowski University in Kielce.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Core-shell magnetic nanoparticles (MNPs) are promising candidates in the development of new treatment methods against infections, including those caused by antibiotic-resistant pathogens. In this study, the bactericidal activity of human antibacterial peptide cathelicidin LL-37, synthetic ceragenins CSA-13 and CSA-131, and classical antibiotics vancomycin and colistin, against methicillin-resistant

Indexed as

Drug SynergismAnti-Bacterial AgentsAntimicrobial Cationic PeptidesCathelicidinsDrug Resistance, BacterialDrug Therapy, CombinationHumansMagnetite NanoparticlesMicrobial Sensitivity TestsPseudomonas aeruginosaStaphylococcus aureusSteroidsAnti-Bacterial AgentsAntimicrobial Cationic PeptidesCathelicidinsceragenin CSA-13Magnetite NanoparticlesSteroidsantibiotic-resistant bacteriacerageninsLL-37 peptidemagnetic nanoparticlessynergistic activity

Identifiers

PMID27799768
PMCPMC5077129

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.